- Home
- PROK vs PSFE Comparison
PROK vs PSFE Comparison
Compare PROK & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PROK | PSFE |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.1M | 455.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PROK | PSFE |
|---|---|---|
| Price | $2.36 | $7.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $7.40 | ★ $10.60 |
| AVG Volume (30 Days) | ★ 1.2M | 556.1K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $744,000.00 | ★ $1,683,103,000.00 |
| Revenue This Year | $918.66 | $1.95 |
| Revenue Next Year | N/A | $6.21 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.46 | $6.43 |
| 52 Week High | $7.13 | $24.11 |
Technical Indicators
Market Signals| Indicator | PROK | PSFE |
|---|---|---|
| Relative Strength Index (RSI) | 49.85 | 41.59 |
| Support Level | $2.06 | $8.05 |
| Resistance Level | $2.29 | $8.55 |
| Average True Range (ATR) | 0.17 | 0.40 |
| MACD | 0.02 | 0.18 |
| Stochastic Oscillator | 50.00 | 45.74 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.